5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Q; Harvey, AR; Macklis, JD; Mellough, CB; Pollett, MA; Snyder, EY; Spalding, KL; Symons, NA | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Fate of multipotent neural precursor cells transplanted into mouse retina selectively depleted of retinal ganglion cells.
Topics: Animals; Animals, Newborn; Apoptosis; Biopsy, Fine-Needle; Calbindins; Cell Count; Cell Survival; Galactosides; Glial Fibrillary Acidic Protein; Glycoside Hydrolases; Immunohistochemistry; In Situ Hybridization; Indoles; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neurofilament Proteins; Neurons; Optic Nerve Injuries; Parvalbumins; Protein Kinase C; Protein Kinase C-alpha; Retina; Retinal Ganglion Cells; S100 Calcium Binding Protein G; Stem Cell Transplantation; Stem Cells; Superior Colliculi; Tubulin; Y Chromosome | 2004 |